Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients.
Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.
Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.
Intended for US audience
Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.
Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.
Intended for US audience
Location: Switzerland, Geneva, Plan-les-Ouates
Employees: 51-200
Total raised: $108.75M
Founded date: 2005
Investors 1
Funding Rounds 3
| Date | Series | Amount | Investors |
| 19.03.2024 | - | $22.61M | - |
| 12.06.2020 | - | $52.51M | - |
| 22.09.2016 | - | $33.63M | - |
Mentions in press and media 11
| Date | Title | Description |
| 28.06.2024 | SPINEART APPOINTS LAURENT NODÉ-LANGLOIS AS CHIEF TECHNOLOGY OFFICER TO LEAD ENABLING TECHNOLOGIES BUSINESS UNIT | GENEVA, June 28, 2024 /PRNewswire/ -- Spineart, a fast-growing company specialized in spine surgery innovation, is pleased to announce the appointment of Laurent Nodé-Langlois as Chief Technology Officer. In his new role, Laurent will be ba... |
| 28.05.2024 | Spineart Receives 510(k) Clearance for SCARLET® AC-Ti Anterior Cervical Cage | GENEVA, May 28, 2024 /PRNewswire/ -- Spineart, a fast-growing company specialized in spine surgery, proudly announces the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCARLET® AC-Ti secured anterior cervical cag... |
| 20.03.2024 | Spineart attracts more than CHF20 million to fuel further growth | Spineart is a Geneva-based medtech company with over €100m (as of 2023) in revenues, is focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, an... |
| 19.03.2024 | Spineart Secures More Than CHF20M in Convertible Financing | Spineart, a Geneva, Switzerland-based spine specialist working with surgeons to accelerate the adoption of technologies, raised more thane CHF20M in convertible financing. Approximately CHF16M of the funding was contributed by existing shar... |
| 11.03.2024 | Artificial Disc Replacement (ADR) Market Predicted to Garner $1.3 Bn by 2030 | CAGR of 12.3% | Vantage Market Research | Vantage Market Research Artificial Disc Replacement Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2030 WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- The Global Artifi... |
| 19.12.2022 | Spineart and Ecential Robotics Annouce a Partnership to Co-develop Spine Surgery Applications and Co-market the Ecential Robotics’ Open Robotic Surgery Platform | Spineart, a leading provider of spine surgery implants and eCential Robotics, a growth MedTech company that designs and produces an open system unifying robotics, surgical navigation, and 2D/3D robotic imaging, announced they entered a long... |
| 12.06.2020 | EGS Beteiligungen invests CHF 50 million in Spineart | Spineart was co-founded in 2005 by Jérome Levieux and Stéphane Mugnier-Jacob, who both have over 20 years’ experience in the spine industry and co-lead Spineart. Over the past 4 years, Geneva-based Spineart has doubled its sales to reach a ... |
| 12.06.2020 | EGS Beteiligungen invests CHF 50 million in Spineart | |
| 22.09.2016 | Spineart Raises €30M in Equity Funding | Spineart, a Geneva, Switzerland-based medical device company, raised €30m in growth equity funding. Gimv and the Gimv Health & Care Fund made the joint investment. The company intends to use the funds for expansion of its sales organiza... |
| 20.09.2016 | Spineart announces a EUR 30 million investment |
Show more